Regencell Bioscience Holdings (RGC) Liabilities and Shareholders Equity (2020 - 2025)

Regencell Bioscience Holdings (RGC) has 3 years of Liabilities and Shareholders Equity data on file, last reported at $3.0 million in Q4 2025.

• Quarterly Liabilities and Shareholders Equity changed N/A year-over-year to $3.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $21.4 million (changed N/A YoY) and the FY2025 annual result came in at $5.8 million, changed N/A from the prior year.
• Liabilities and Shareholders Equity fell to $3.0 million in Q4 2025, from $5.8 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $12.6 million in Q2 2023 to a low of $3.0 million in Q4 2025.